Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: mTOR signalling pathway has emerged as a promising target for well-differentiated endocrine pancreatic carcinoma therapy. Because of varying behavior, INT are usually excluded from clinical trials employing the mTOR inhibitor, RAD001.
Conference: 10th Annual ENETSConcerence (2013)
Presenting Author: MILIONE M
Authors: Milione M, Pusceddu S, Buzzoni R, Damato A, Coppa J,
Introduction: The behavior of liver metastasis from endocrine pancreatic carcinoma is eterogeneous, and several treatments have been proposed, but no single option is ideal.
Conference: 7th Annual ENETSConcerence (2010)
Presenting Author: Zerbi A
Authors: Capitanio V, Papa M, Zerbi A, Vitali G, De Cobelli F,
Keywords: endocrine tumor, liver metastasis, chemoembolization,
Introduction: Pancreatic endocrine tumors (pNETs) are rare but are among the most common neuroendocrine neoplasms of the abdomen. At diagnosis, many of them are already advanced and difficult to treat.
Conference: 7th Annual ENETSConcerence (2010)
Presenting Author:
Authors: Kaemmerer D, Vikas P, Daffner W, Hörsch D, Klöppel G,
Keywords: endocrine pancreatic carcinoma, peptide receptor radionuclide therapy, neodjuvant treatment, pancreatic surgery, molecular imaging, receptor PET/CT,